Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Enveric Biosciences, Inc. (ENVB)
USD1.32
+0.00 (+0.00%)
US NASDAQ Healthcare Biotechnology
Address
4851 Tamiami Trail North 34103
Naples, FL, US
Naples, FL, US
CEO
Joseph Edward Tucker
Website
enveric.com
IPO
2015-05-04
CIK 890821 ISIN US29405E5050
Description
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Jay Pharma | AMRH | 2020-05-27 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.32
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
1.10
Float Shares
545.9K
Free Float %
91.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.91% | -0.89% | -34.12% | +0.00% | -62.81% | -38.84% | -85.08% | -99.58% | -99.99% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
1.32
DCF (Unlevered)
12.40
+839.2%
DCF (Levered)
13.97
+958.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-31.85
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+84.1% ★ Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: -4,297.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+698.7% Q1'26: +1,006,834.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
48.59M
est: 48.15M (+0.9%)
|
43.00M
est: 41.31M (+4.1%)
|
39.91M
est: 43.37M (-8.0%)
|
—
|
—
est: 10.00M (-100.0%)
|
10.00M
10.00M – 10.00M
+0.0% YoY
|
15.00M
15.00M – 15.00M
+50.0% YoY
|
25.00M
25.00M – 25.00M
+66.7% YoY
|
| EBITDA |
-7.67M
|
-6.92M
|
-2.26M
|
-9.23M
|
-8.57M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-10.89M
|
-9.82M
|
-4.52M
|
-9.57M
|
-8.77M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-9.07M
est: -24.52B (+100.0%)
|
-16.90M
est: -1.13B (+98.5%)
|
-5.60M
est: 6.03B (-100.1%)
|
-9.57M
est: -8.75M (-9.4%)
|
-12.13M
est: -51.81M (+76.6%)
|
-105.44M
-105.44M – -105.44M
-103.5% YoY
|
-37.35M
-37.35M – -37.35M
+64.6% YoY
|
-14.46M
-14.46M – -14.46M
+61.3% YoY
|
| SGA |
18.51M
|
10.79M
|
12.21M
|
6.45M
|
5.79M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-36,347.76
est: -585,000.00 (+93.8%)
|
-42,616.68
est: -27,000.00 (-57.8%)
|
-2,543.88
est: 144,000.00 (-101.8%)
|
-228.48
est: -208.80 (-9.4%)
|
-36.24
est: -154.80 (+76.6%)
|
-315.00
-315.00 – -315.00
-103.5% YoY
|
-111.60
-111.60 – -111.60
+64.6% YoY
|
-43.20
-43.20 – -43.20
+61.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-8.14M
OE per share TTM
-15,960.92
Owner's Yield
-256.19%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
5.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
11
Total invested
106.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JEFFREY E. EBERWEIN | 7.15M | 37.80% | 7.15M | — | 7.15M | 10.00 | IN | USA | 2016-05-18 | ↗ |
| 2 | LONE STAR VALUE MANAGEMENT, LLC | 7.15M | 37.80% | 7.15M | — | 7.15M | 10.00 | OO | CONNECTICUT | 2016-05-18 | ↗ |
| 3 | LONE STAR VALUE INVESTORS GP, LLC | 7.11M | 37.60% | 7.11M | — | 7.11M | 10.00 | OO | DELAWARE | 2016-05-18 | ↗ |
| 4 | LONE STAR VALUE INVESTORS, LP | 7.11M | 37.60% | 7.11M | — | 7.11M | 10.00 | PN | DELAWARE | 2016-05-18 | ↗ |
| 5 | SRINIDHI “DEV” DEVANUR | 5.98M | 47.80% | 5.98M | — | 5.98M | 10.00 | IN | INDIA | 2015-06-03 | ↗ |
| 6 | Identification Nos. of above persons (. | 4.00M | 17.49% | 2.35M | 4.00M | 2.35M | 10.00 | OO | United States | 2018-11-08 | ↗ |
| 7 | 13G | 2.50M | 9.90% | — | 2.50M | — | 2.50M | IN | Texas | 2018-08-09 | ↗ |
| 8 | TO Pharmaceuticals LLC | 2.30M | 19.80% | 2.30M | — | 2.30M | — | PN | Delaware | 2021-02-10 | ↗ |
| 9 | TOP Invest LLC | 2.30M | 19.80% | 2.30M | — | 2.30M | — | PN | Delaware | 2021-02-10 | ↗ |
| 10 | GIRI DEVANUR | 2.18M | 17.40% | 2.18M | — | 2.18M | 10.00 | IN | INDIA | 2015-06-03 | ↗ |
| 11 | Bezalel Partners, LLC | 1.15M | 9.99% | 1.15M | — | 1.15M | — | OO | USA | 2021-02-10 | ↗ |
| 12 | David Stefansky | 1.15M | 9.99% | 1.15M | — | 1.15M | — | IN | USA | 2021-02-10 | ↗ |
| 13 | Dhruwa Narain Rai | 978.8K | 5.64% | 978.8K | — | — | — | IN | USA | 2018-01-03 | ↗ |
| 14 | Pinches Abowitz | 934.3K | 8.00% | 934.3K | — | 934.3K | — | IN | New York | 2021-01-12 | ↗ |
| 15 | TAF Group LLC | 934.3K | 8.00% | 934.3K | — | 934.3K | — | PN | New York | 2021-01-12 | ↗ |
| 16 | Waqas Khatri | 667.0K | 1.10% | 667.0K | — | 667.0K | — | IN | Pakistan | 2019-09-27 | ↗ |
| 17 | Armistice Capital, LLC | 273.1K | 9.99% | — | 273.1K | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 18 | Steven Boyd | 273.1K | 9.99% | — | 273.1K | — | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 19 | B. Asher | 129.8K | 9.99% | — | 129.8K | — | 129.8K | HC | United States of America | 2022-08-01 | ↗ |
| 20 | Capital LLC | 129.8K | 9.99% | — | 129.8K | — | 129.8K | OO | United States of America | 2022-08-01 | ↗ |
| 21 | P. Kopin | 129.8K | 9.99% | — | 129.8K | — | 129.8K | HC | United States of America | 2022-08-01 | ↗ |
| 22 | AdvisorShares Trust | 116.3K | 5.60% | 116.3K | — | 116.3K | — | IV | Delaware | 2023-02-14 | ↗ |
| 23 | Hudson Bay Capital Management LP | 110.4K | 5.04% | — | 110.4K | — | — | PN | State of Delaware | 2023-02-07 | ↗ |
| 24 | Sander Gerber | 110.4K | 5.04% | — | 110.4K | — | — | IN | State of Delaware | 2023-02-07 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
11
+0 vs prev Q
New positions
2
Closed positions
2
Increased
4
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 32.1K +32.1K (+100.0%) | 62.4K +62.4K (+100.0%) | 2.13% +2.129 pp | 0.00% +0.000 pp | USD1.94 +0.0% | 1 qtrs NEW |
| 2 | ADVISORSHARES INVESTMENTS LLC | 17.0K +— (+0.0%) | 32.9K -28.7K (-46.6%) | 1.12% -0.475 pp | 0.01% -0.004 pp | USD3.63 -46.6% | 2 qtrs — |
| 3 | UBS GROUP AG | 3.6K +717.0 (+24.8%) | 7.0K -3.5K (-33.3%) | 0.24% -0.034 pp | 0.00% +0.000 pp | USD3.29 -41.0% | 2 qtrs — |
| 4 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.1K -814.0 (-42.5%) | 2.1K -4.8K (-69.2%) | 0.07% -0.108 pp | 0.00% 0.000 pp | USD3.63 -46.6% | 2 qtrs — |
| 5 | JONES FINANCIAL COMPANIES LLLP | 1.0K +1.0K (+100.0%) | 1.9K +1.9K (+100.0%) | 0.07% +0.066 pp | 0.00% +0.000 pp | USD1.94 +0.0% | 1 qtrs NEW |
| 6 | SBI SECURITIES CO., LTD. | 83.00 +34.0 (+69.4%) | 161.00 -17.0 (-9.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD2.92 -33.6% | 2 qtrs — |
| 7 | BLACKROCK, INC. | 51.00 +— (+0.0%) | 99.00 -86.0 (-46.5%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.63 -46.6% | 2 qtrs — |
| 8 | WELLS FARGO & COMPANY/MN | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -35.3% | 2 qtrs — |
| 9 | DANSKE BANK A/S | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -35.3% | 2 qtrs — |
| 10 | GROUP ONE TRADING, L.P. | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -35.3% | 2 qtrs — |
| 11 | NATIONAL BANK OF CANADA /FI/ | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -35.3% | 2 qtrs — |
| 12 | CITIGROUP INC | — -2.3K (-100.0%) | — -8.3K (-100.0%) | 0.00% -0.214 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 13 | BANK OF AMERICA CORP /DE/ | — -5.0 (-100.0%) | — -18.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF PSIL | 0.11% | 48.2K | 1.84% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 33.5K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
520.4K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+520,410
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | WEBB MICHAEL D | Director | A-Award | A | Common Stock | 7,633 | 0.00 | — | 7,898 | D | ↗ |
| 2025-12-23 | Tucker Joseph Edward | Director / Officer | A-Award | A | Common Stock | 60,296 | 0.00 | — | 70,355 | D | ↗ |
| 2025-12-23 | Schabacker Marcus | Director | A-Award | A | Common Stock | 7,633 | 0.00 | — | 7,900 | D | ↗ |
| 2025-12-23 | PASQUALONE FRANK | Director | A-Award | A | Common Stock | 7,633 | 0.00 | — | 7,904 | D | ↗ |
| 2025-12-23 | Kegler George A. | Director | A-Award | A | Common Stock | 7,633 | 0.00 | — | 7,900 | D | ↗ |
| 2025-12-23 | DeWitt Sheila | Director | A-Award | A | Common Stock | 7,633 | 0.00 | — | 7,788 | D | ↗ |
| 2025-12-23 | Coveney Kevin Michael | Officer | A-Award | A | Common Stock | 40,198 | 0.00 | — | 47,413 | D | ↗ |
| 2025-05-08 | Tucker Joseph Edward | Director / Officer | A-Award | A | Common Stock | 98,866 | 0.00 | — | 120,711 | D | ↗ |
| 2025-05-08 | Facchini Peter J. | Officer | A-Award | A | Common Stock | 24,717 | 0.00 | — | 33,058 | D | ↗ |
| 2025-05-08 | Coveney Kevin Michael | Officer | A-Award | A | Common Stock | 74,150 | 0.00 | — | 86,584 | D | ↗ |
| 2024-10-09 | WEBB MICHAEL D | Director | A-Award | A | Common Stock | 47,733 | 0.00 | — | 47,733 | D | ↗ |
| 2024-10-09 | Tucker Joseph Edward | Director / Officer | A-Award | A | Common Stock | 161,633 | 0.00 | — | 335,829 | D | ↗ |
| 2024-10-09 | Schabacker Marcus | Director | A-Award | A | Common Stock | 47,733 | 0.00 | — | 48,053 | D | ↗ |
| 2024-10-09 | PASQUALONE FRANK | Director | A-Award | A | Common Stock | 47,733 | 0.00 | — | 48,733 | D | ↗ |
| 2024-10-09 | Kegler George A. | Director | A-Award | A | Common Stock | 47,733 | 0.00 | — | 48,053 | D | ↗ |
| 2024-10-09 | Facchini Peter J. | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 130,856 | D | ↗ |
| 2024-10-09 | DeWitt Sheila | Director | A-Award | A | Common Stock | 27,845 | 0.00 | — | 27,845 | D | ↗ |
| 2024-10-09 | Coveney Kevin Michael | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 186,500 | D | ↗ |
| 2024-05-28 | DeWitt Sheila | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-02-22 | Tucker Joseph Edward | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 174,196 | — | ↗ |
| 2024-02-22 | Facchini Peter J. | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 90,856 | — | ↗ |
| 2024-02-22 | Coveney Kevin Michael | Officer | A-Award | A | Common Stock | 60,000 | 0.00 | — | 86,500 | — | ↗ |
| 2023-09-15 | PASQUALONE FRANK | Director | P-Purchase | A | Common Stock | 1,000 | 2.14 | 2.1K | 1,000 | — | ↗ |
| 2023-03-13 | Coveney Kevin Michael | Officer | A-Award | A | Common Stock | 26,500 | 0.00 | — | 26,500 | — | ↗ |
| 2023-01-25 | Tucker Joseph Edward | Officer | A-Award | A | Common Stock | 44,000 | 0.00 | — | 74,196 | — | ↗ |
| 2023-01-25 | Kanubaddi Avani | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 48,346 | — | ↗ |
| 2023-01-25 | Hagel Jillian Marie | Officer | A-Award | A | Common Stock | 12,000 | 0.00 | — | 35,802 | — | ↗ |
| 2023-01-25 | Facchini Peter J. | Officer | A-Award | A | Common Stock | 17,000 | 0.00 | — | 40,865 | — | ↗ |
| 2022-09-09 | Dickey Robert IV | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-13 | PASQUALONE FRANK | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-13 | WEBB MICHAEL D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-13 | O'NEIL BEVIN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-19 | Ward Carter Julian | Officer | A-Award | A | Restricted Stock Units | 744,429 | 0.00 | — | 744,429 | — | ↗ |
| 2022-01-19 | Kanubaddi Avani | Officer | A-Award | A | Restricted Stock Units | 1,127,787 | 0.00 | — | 1,127,787 | — | ↗ |
| 2021-10-13 | Tucker Joseph Edward | Officer | A-Award | A | Common Stock | 1,374 | 0.00 | — | 15,196 | — | ↗ |
| 2021-10-13 | Hagel Jillian Marie | Officer | A-Award | A | Common Stock | 1,021 | 0.00 | — | 13,302 | — | ↗ |
| 2021-10-13 | Facchini Peter J. | Officer | A-Award | A | Common Stock | 1,021 | 0.00 | — | 13,356 | — | ↗ |
| 2021-09-16 | Tucker Joseph Edward | Director / Officer | A-Award | A | Common Warrants | 13,290 | 2.82 | 37.5K | 13,290 | I | ↗ |
| 2021-09-16 | Thompson Bradley George | Director | A-Award | A | Stock Options | 53,160 | 0.94 | 50.0K | 53,160 | — | ↗ |
| 2021-09-16 | Hagel Jillian Marie | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-16 | Facchini Peter J. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-15 | Ward Carter Julian | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-18 | LIND DOUGLAS | Director | A-Award | A | Common Stock | 2,265 | 0.00 | — | 2,265 | — | ↗ |
| 2021-03-17 | LIND DOUGLAS | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-04 | Van Buiten John | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2021-02-15 | Schabacker Marcus | Director | A-Award | A | Common Stock | 15,957 | 0.00 | — | 15,957 | — | ↗ |
| 2021-02-15 | Mayer Solomon | Director | A-Award | A | Common Stock | 15,957 | 0.00 | — | 15,957 | — | ↗ |
| 2021-02-15 | Kegler George A. | Director | A-Award | A | Common Stock | 15,957 | 0.00 | — | 15,957 | — | ↗ |
| 2021-02-15 | Kanubaddi Avani | Officer | A-Award | A | Restricted Stock Units | 789,484 | 0.00 | — | 789,484 | — | ↗ |
| 2021-02-15 | Johnson David Ian | Director / Officer | A-Award | A | Restricted Stock Units | 53,192 | 0.00 | — | 1,368,999 | — | ↗ |
| 2020-12-30 | Wilkins Robert G. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | Van Buiten John | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | TOP Invest LLC | 10% Owner | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 2,299,001 | — | ↗ |
| 2020-12-30 | Schabacker Marcus | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | Mayer Solomon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | Kegler George A. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | Kanubaddi Avani | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-30 | Johnson David Ian | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-05 | Kelton Brent | Officer | J-Other | A | Common Stock | 986,777 | 0.00 | — | 1,079,953 | — | ↗ |
| 2018-12-11 | Sukumaran Thoranath | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-11-16 | Sikaria Lokesh | 10% Owner | S-Sale | D | Common Stock | 1,850 | 0.29 | 543.90 | 2,308,850 | — | ↗ |
| 2018-11-16 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 | 10% Owner | S-Sale | D | Common Stock | 14,119 | 0.30 | 4.2K | 2,332,808 | — | ↗ |
| 2018-11-16 | Sikaria Chanda | 10% Owner | S-Sale | D | Common Stock | 58,850 | 0.29 | 17.2K | 2,250,000 | — | ↗ |
| 2018-11-16 | Lokesh Sikaria Trust Dated 12/14/2012 | 10% Owner | S-Sale | D | Common Stock | 58,850 | 0.29 | 17.2K | 2,250,000 | — | ↗ |
| 2018-10-26 | Sikaria Lokesh | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,650,000 | — | ↗ |
| 2018-10-26 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,650,000 | — | ↗ |
| 2018-10-26 | Sikaria Chanda | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,650,000 | — | ↗ |
| 2018-10-26 | Lokesh Sikaria Trust Dated 12/14/2012 | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,650,000 | — | ↗ |
| 2018-10-17 | Kostiner Barry | Officer | A-Award | A | Option (Right to Buy) | 150,000 | 1.13 | 169.5K | 150,000 | — | ↗ |
| 2018-09-12 | Patel Viraj J | Officer | A-Award | A | Option (Right to Buy) | 200,000 | 1.45 | 290.0K | 200,000 | — | ↗ |
| 2018-09-12 | Kelton Brent | Officer | A-Award | A | Option (Right to Buy) | 250,000 | 1.45 | 362.5K | 250,000 | — | ↗ |
| 2018-08-20 | Shawah Robert G. | Director | A-Award | A | Option (Right to Buy) | 35,000 | 1.53 | 53.6K | 35,000 | — | ↗ |
| 2018-08-20 | Shad James | Director | A-Award | A | Restricted Stock Unit | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2018-08-20 | LUCI DAVID P | Director | A-Award | A | Restricted Stock Unit | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2018-08-20 | Eberwein Jeffrey E. | 10% Owner | J-Other | A | 9.00% Series A Cumulative Preferred Stock | 5,057 | 0.00 | — | 159,950 | — | ↗ |
| 2018-08-20 | Angelis Dimitrios | Director | A-Award | A | Restricted Stock Unit | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2018-08-16 | Shawah Robert G. | Director | — | D | Common Stock | 0 | 0.00 | — | 400 | — | ↗ |
| 2018-08-16 | Shad James | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-08-16 | Eberwein Jeffrey E. | 10% Owner | J-Other | A | Warrant (Right to Buy) | 1,910,397 | 1.50 | 2.87M | 1,910,397 | — | ↗ |
| 2018-07-17 | Devanur Giri | 10% Owner | S-Sale | D | Common stock | 100,000 | 2.27 | 226.6K | 1,761,989 | — | ↗ |
| 2018-07-09 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | A | Common Stock | 1,135,768 | 0.00 | — | 1,182,932 | — | ↗ |
| 2018-06-12 | Devanur Giri | 10% Owner | P-Purchase | A | Warrant | 25,000 | 0.27 | 6.8K | 37,121 | — | ↗ |
| 2018-06-07 | Devanur Giri | 10% Owner | S-Sale | D | Common stock | 329,357 | 2.01 | 661.3K | 1,861,989 | — | ↗ |
| 2018-03-31 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | D | Common Stock | 83,308 | 0.00 | — | 0 | — | ↗ |
| 2018-02-14 | Langer Arthur M | Director | J-Other | A | Common Stock | 7,381 | 0.00 | — | 84,923 | — | ↗ |
| 2018-02-14 | Balakrishnan Venkatraman | Director | J-Other | A | Common Stock | 4,429 | 0.00 | — | 16,948 | — | ↗ |
| 2018-02-14 | Angelis Dimitrios | Director | J-Other | A | Common Stock | 8,784 | 0.00 | — | 40,990 | — | ↗ |
| 2018-02-09 | Rai Dhruwa N | Director | J-Other | A | Common Stock | 4,921 | 0.00 | — | 1,164,713 | — | ↗ |
| 2018-02-09 | Pearse Robert G. | Director | J-Other | A | Common Stock | 8,710 | 0.00 | — | 40,473 | — | ↗ |
| 2018-02-09 | Kelton Brent | Officer | J-Other | A | Common Stock | 85,003 | 0.00 | — | 93,176 | — | ↗ |
| 2018-02-09 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | A | Common Stock | 10,113 | 0.00 | — | 47,164 | — | ↗ |
| 2018-02-08 | Rai Dhruwa N | Director | A-Award | A | Common Stock | 170,000 | 0.00 | — | 1,159,792 | — | ↗ |
| 2018-02-08 | LUCI DAVID P | Director | — | D | Common Stock | 0 | 0.00 | — | 2,430 | — | ↗ |
| 2018-01-01 | Rai Dhruwa N | Director | M-Exempt | D | Restricted Stock Unit | 7,680 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Pearse Robert G. | Director | M-Exempt | D | Restricted Stock Unit | 9,063 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Langer Arthur M | Director | M-Exempt | D | Restricted Stock Unit | 7,680 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Eberwein Jeffrey E. | Director / 10% Owner | M-Exempt | A | Common Stock | 9,985 | 0.00 | — | 37,051 | — | ↗ |
| 2018-01-01 | Balakrishnan Venkatraman | Director | M-Exempt | D | Restricted Stock Unit | 9,524 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Angelis Dimitrios | Director | M-Exempt | D | Restricted Stock Unit | 8,602 | 0.00 | — | 0 | — | ↗ |
| 2017-12-29 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | A | 9.00% Series A Cumulative Preferred Stock | 21,410 | 50.00 | 1.07M | 405,395 | — | ↗ |
| 2017-12-26 | Kelton Brent | Officer | — | D | Common Stock | 0 | 0.00 | — | 8,173 | — | ↗ |
| 2017-12-21 | Rai Dhruwa N | Director | M-Exempt | A | Common Stock | 333,333 | 0.00 | — | 982,112 | — | ↗ |
| 2017-11-17 | Rai Dhruwa N | Director | P-Purchase | A | Warrant (Right to Buy) | 145,450 | 4.12 | 598.5K | 145,450 | — | ↗ |
| 2017-11-17 | LUCI DAVID P | Director | — | D | Warrant (Right to Buy) | 2,430 | 4.12 | 10.0K | 0 | — | ↗ |
| 2017-11-17 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 100,000 | 4.12 | 411.5K | 2,972,592 | — | ↗ |
| 2017-11-17 | Devanur Giri | Officer | P-Purchase | A | Common Stock | 12,121 | 4.12 | 49.9K | 2,191,346 | — | ↗ |
| 2017-10-30 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 1,303 | 6.50 | 8.5K | 13,910 | — | ↗ |
| 2017-10-27 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 6.50 | 16.3K | 12,607 | — | ↗ |
| 2017-10-26 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 3 | 6.25 | 18.75 | 10,107 | — | ↗ |
| 2017-09-26 | Eberwein Jeffrey E. | Director / 10% Owner | X-InTheMoney | A | Common Stock | 1,205,837 | 0.00 | — | 2,872,592 | — | ↗ |
| 2017-09-11 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | A | 9.00% Series A Cumulative Preferred Stock | 10,277 | 50.00 | 513.9K | 383,985 | — | ↗ |
| 2017-09-06 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 7,500 | 6.50 | 48.8K | 10,104 | — | ↗ |
| 2017-08-21 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 2,604 | 6.50 | 16.9K | 2,604 | — | ↗ |
| 2017-05-19 | Rai Dhruwa N | Director | M-Exempt | A | Common Stock | 3,329 | 0.00 | — | 503,329 | — | ↗ |
| 2017-05-19 | Pearse Robert G. | Director | M-Exempt | A | Restricted Stock Unit | 5,891 | 0.00 | — | 0 | — | ↗ |
| 2017-05-19 | Langer Arthur M | Director | M-Exempt | A | Restricted Stock Unit | 4,992 | 0.00 | — | 0 | — | ↗ |
| 2017-05-19 | Eberwein Jeffrey E. | Director / 10% Owner | M-Exempt | A | Restricted Stock Unit | 6,839 | 0.00 | — | 0 | — | ↗ |
| 2017-05-19 | Balakrishnan Venkatraman | Director | M-Exempt | A | Common Stock | 2,995 | 0.00 | — | 2,995 | — | ↗ |
| 2017-05-19 | Angelis Dimitrios | Director | M-Exempt | A | Restricted Stock Unit | 5,941 | 0.00 | — | 0 | — | ↗ |
| 2017-05-04 | Patel Viraj J | Officer | A-Award | A | Option (Right to Buy) | 75,000 | 6.59 | 494.3K | 75,000 | — | ↗ |
| 2017-05-01 | Rai Dhruwa N | Director | M-Exempt | A | Common Stock | 5,121 | 0.00 | — | 505,121 | — | ↗ |
| 2017-05-01 | Pearse Robert G. | Director | M-Exempt | A | Common Stock | 9,063 | 0.00 | — | 52,872 | — | ↗ |
| 2017-05-01 | Langer Arthur M | Director | M-Exempt | A | Common Stock | 7,680 | 0.00 | — | 72,550 | — | ↗ |
| 2017-05-01 | Eberwein Jeffrey E. | Director / 10% Owner | M-Exempt | A | Common Stock | 10,522 | 0.00 | — | 30,749 | — | ↗ |
| 2017-05-01 | Balakrishnan Venkatraman | Director | M-Exempt | A | Common Stock | 4,608 | 0.00 | — | 4,608 | — | ↗ |
| 2017-05-01 | Angelis Dimitrios | Director | M-Exempt | A | Common Stock | 9,140 | 0.00 | — | 17,663 | — | ↗ |
| 2017-04-28 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 5 | 6.51 | 32.55 | 83,308 | — | ↗ |
| 2017-04-24 | Patel Viraj J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-04-21 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 23 | 6.51 | 149.73 | 83,303 | — | ↗ |
| 2017-04-19 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 2 | 6.51 | 13.02 | 83,280 | — | ↗ |
| 2017-04-17 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 170 | 6.51 | 1.1K | 83,278 | — | ↗ |
| 2017-04-11 | Rai Dhruwa N | Director | A-Award | A | Restricted Stock Unit | 5,121 | 0.00 | — | 5,121 | — | ↗ |
| 2017-04-11 | Pearse Robert G. | Director | A-Award | A | Restricted Stock Unit | 9,063 | 0.00 | — | 9,063 | — | ↗ |
| 2017-04-11 | Langer Arthur M | Director | A-Award | A | Restricted Stock Unit | 7,680 | 0.00 | — | 7,680 | — | ↗ |
| 2017-04-11 | Eberwein Jeffrey E. | Director / 10% Owner | A-Award | A | Restricted Stock Unit | 9,985 | 0.00 | — | 9,985 | — | ↗ |
| 2017-04-11 | Devanur Giri | Officer | A-Award | A | Common Stock | 100 | 0.00 | — | 2,179,225 | — | ↗ |
| 2017-04-11 | Balakrishnan Venkatraman | Director | A-Award | A | Restricted Stock Unit | 4,608 | 0.00 | — | 4,608 | — | ↗ |
| 2017-04-11 | Angelis Dimitrios | Director | A-Award | A | Restricted Stock Unit | 8,602 | 0.00 | — | 8,602 | — | ↗ |
| 2017-03-30 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 223 | 6.51 | 1.5K | 83,108 | — | ↗ |
| 2017-03-07 | LUCI DAVID P | Director | — | D | 8% Convertible Note due March 2020 | 0 | 2.80 | — | 0 | — | ↗ |
| 2017-03-03 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 22 | 6.51 | 143.22 | 82,885 | — | ↗ |
| 2017-03-02 | Rai Dhruwa N | Director | P-Purchase | A | 8% Convertible Note due March 2020 | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-02-21 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 57 | 6.51 | 371.07 | 82,863 | — | ↗ |
| 2017-02-17 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 1 | 6.51 | 6.51 | 82,806 | — | ↗ |
| 2017-02-15 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 10 | 6.51 | 65.10 | 82,805 | — | ↗ |
| 2017-02-10 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 434 | 6.51 | 2.8K | 82,795 | — | ↗ |
| 2017-02-08 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 31 | 6.51 | 201.81 | 82,361 | — | ↗ |
| 2017-01-30 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 143 | 6.51 | 930.93 | 82,330 | — | ↗ |
| 2017-01-24 | Rosenberg Robert Alan | Director | M-Exempt | A | Common Stock | 14,245 | 0.00 | — | 69,370 | — | ↗ |
| 2017-01-24 | Pearse Robert G. | Director | M-Exempt | A | Common Stock | 16,809 | 0.00 | — | 16,809 | — | ↗ |
| 2017-01-24 | Langer Arthur M | Director | M-Exempt | A | Common Stock | 14,245 | 0.00 | — | 64,870 | — | ↗ |
| 2017-01-24 | Eberwein Jeffrey E. | Director / 10% Owner | M-Exempt | A | Restricted Stock Unit | 20,227 | 0.00 | — | 0 | — | ↗ |
| 2017-01-24 | Angelis Dimitrios | Director | M-Exempt | A | Restricted Stock Unit | 17,663 | 0.00 | — | 0 | — | ↗ |
| 2017-01-23 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 2,130 | 6.51 | 13.9K | 82,187 | — | ↗ |
| 2017-01-20 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 124 | 6.51 | 807.24 | 80,057 | — | ↗ |
| 2017-01-18 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 6.51 | 65.1K | 79,933 | — | ↗ |
| 2017-01-11 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 22 | 6.51 | 143.22 | 69,933 | — | ↗ |
| 2016-12-30 | Eberwein Jeffrey E. | Director / 10% Owner | J-Other | A | 9.00% Series A Cumulative Preferred Stock | 363,611 | 50.00 | 18.18M | 363,611 | — | ↗ |
| 2016-12-29 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 706 | 6.51 | 4.6K | 69,871 | — | ↗ |
| 2016-12-28 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 800 | 6.51 | 5.2K | 69,165 | — | ↗ |
| 2016-12-22 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 700 | 6.51 | 4.6K | 68,365 | — | ↗ |
| 2016-12-15 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 2 | 6.51 | 13.02 | 67,665 | — | ↗ |
| 2016-12-02 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 1 | 6.51 | 6.51 | 67,663 | — | ↗ |
| 2016-11-30 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 807 | 6.51 | 5.3K | 67,662 | — | ↗ |
| 2016-11-29 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 35 | 6.51 | 227.85 | 66,855 | — | ↗ |
| 2016-11-25 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 2 | 6.51 | 13.02 | 66,820 | — | ↗ |
| 2016-11-22 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 23 | 6.51 | 149.73 | 66,818 | — | ↗ |
| 2016-11-15 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 3 | 6.51 | 19.53 | 66,795 | — | ↗ |
| 2016-10-27 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 1 | 6.51 | 6.51 | 66,792 | — | ↗ |
| 2016-10-25 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 6 | 6.51 | 39.06 | 66,791 | — | ↗ |
| 2016-10-20 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 126 | 6.51 | 820.26 | 66,785 | — | ↗ |
| 2016-10-19 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 400 | 6.51 | 2.6K | 66,659 | — | ↗ |
| 2016-10-18 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 25 | 6.51 | 162.75 | 66,259 | — | ↗ |
| 2016-09-26 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 183 | 6.51 | 1.2K | 66,234 | — | ↗ |
| 2016-09-02 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 471 | 6.51 | 3.1K | 66,051 | — | ↗ |
| 2016-09-01 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 18,214 | 6.51 | 118.6K | 65,580 | — | ↗ |
| 2016-09-01 | Devanur Srinidhi | Director / Officer / 10% Owner | J-Other | A | Common Stock | 299,250 | 1.00 | 299.3K | 6,276,375 | — | ↗ |
| 2016-08-31 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 1,013 | 6.51 | 6.6K | 47,366 | — | ↗ |
| 2016-08-29 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 81 | 6.51 | 527.31 | 46,353 | — | ↗ |
| 2016-08-25 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 50 | 6.51 | 325.50 | 46,272 | — | ↗ |
| 2016-08-24 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 400 | 6.51 | 2.6K | 46,222 | — | ↗ |
| 2016-08-22 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 26 | 6.51 | 169.26 | 45,822 | — | ↗ |
| 2016-08-19 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 897 | 6.51 | 5.8K | 45,796 | — | ↗ |
| 2016-08-09 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 124 | 6.51 | 807.24 | 44,799 | — | ↗ |
| 2016-07-27 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 103 | 6.51 | 670.53 | 44,675 | — | ↗ |
| 2016-07-25 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 308 | 6.51 | 2.0K | 44,572 | — | ↗ |
| 2016-07-12 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 200 | 6.51 | 1.3K | 44,264 | — | ↗ |
| 2016-07-06 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 860 | 6.51 | 5.6K | 44,064 | — | ↗ |
| 2016-07-01 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 500 | 6.51 | 3.3K | 43,204 | — | ↗ |
| 2016-06-28 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 28 | 6.51 | 182.28 | 42,704 | — | ↗ |
| 2016-06-28 | Balakrishnan Venkatraman | Director | A-Award | A | Option (Right to Buy) | 25,000 | 6.51 | 162.8K | 25,000 | — | ↗ |
| 2016-06-14 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 84 | 6.51 | 546.84 | 42,676 | — | ↗ |
| 2016-06-13 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 6.51 | 6.5K | 42,592 | — | ↗ |
| 2016-06-07 | Eberwein Jeffrey E. | Director / 10% Owner | L-Small | A | Common Stock | 9 | 6.51 | 58.59 | 41,592 | — | ↗ |
| 2016-06-06 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 314 | 6.51 | 2.0K | 41,583 | — | ↗ |
| 2016-06-03 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 9 | 6.51 | 58.59 | 41,269 | — | ↗ |
| 2016-06-02 | Eberwein Jeffrey E. | Director / 10% Owner | P-Purchase | A | Common Stock | 481 | 6.51 | 3.1K | 41,260 | — | ↗ |
| 2016-05-27 | Rosenberg Robert Alan | Director | — | D | Option (Right to Buy) | 25,000 | 2.00 | 50.0K | 0 | — | ↗ |
| 2016-05-27 | Pearse Robert G. | Director | — | D | Option (Right to Buy) | 25,000 | 2.00 | 50.0K | 0 | — | ↗ |
| 2016-05-27 | Langer Arthur M | Director | — | D | Option (Right to Buy) | 25,000 | 2.00 | 50.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
597.0K
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph Tucker Chief Executive Officer | 472.4K | — | 407.1K | — | — | — | 879.5K | 46.29% | ↗ |
| 2 | 2025 | Kevin Coveney Chief Financial Officer | 396.6K | — | 281.9K | — | — | — | 678.4K | 41.55% | ↗ |
| 3 | 2025 | Peter Facchini, Ph.D. Chief Innovation Officer | 221.8K | — | 31.4K | — | — | — | 253.2K | 12.40% | ↗ |
| 4 | 2024 | Joseph Tucker Chief Executive Officer | 458.6K | — | 152.9K | — | — | — | 611.5K | 25.00% | ↗ |
| 5 | 2024 | Kevin Coveney Chief Financial Officer | 385.0K | — | 93.0K | — | — | — | 478.0K | 19.46% | ↗ |
| 6 | 2024 | Peter Facchini, Ph.D. Chief Innovation Officer | 215.3K | — | 59.3K | — | — | — | 274.6K | 21.60% | ↗ |
| 7 | 2023 | Joseph Tucker Chief Executive Officer | 450.8K | — | 126.3K | — | — | — | 577.1K | 21.89% | ↗ |
| 8 | 2023 | Avani Kanubaddi Former President and Chief Operating Officer | 422.8K | — | 28.7K | — | — | — | 451.5K | 6.36% | ↗ |
| 9 | 2023 | Kevin Coveney Chief Financial Officer | 309.0K | — | 49.7K | — | — | — | 358.7K | 13.85% | ↗ |
| 10 | 2023 | Peter Facchini, Ph.D. Chief Innovation Officer | 233.3K | — | 48.8K | — | — | — | 282.1K | 17.31% | ↗ |
| 11 | 2022 | Avani Kanubaddi Former President and Chief Operating Officer | 335.8K | — | 755.6K | — | 209.1K | — | 1.30M | 58.10% | ↗ |
| 12 | 2022 | Joseph Tucker Chief Executive Officer | 361.7K | — | — | — | 270.3K | 194.0K | 825.9K | 0.00% | ↗ |
| 13 | 2022 | Peter Facchini, Ph.D. Chief Innovation Officer | 221.8K | — | — | — | 110.6K | — | 332.4K | 0.00% | ↗ |
| 14 | 2021 | David Johnson Executive Chairman | 250.0K | 168.8K | — | — | — | — | 6.89M | 0.00% | ↗ |
| 15 | 2021 | David Johnson Executive Chairman, Director, and Former Chief Executive Officer | 250.0K | 168.8K | — | — | — | — | 6.89M | 0.00% | ↗ |
| 16 | 2021 | Avani Kanubaddi Former President and Chief Operating Officer | 302.5K | — | 3.79M | — | 144.6K | — | 4.24M | 89.45% | ↗ |
| 17 | 2021 | Avani Kanubaddi President and Chief Operating Officer | 302.5K | 144.6K | — | — | — | — | 4.24M | 0.00% | ↗ |
| 18 | 2021 | Joseph Tucker Chief Executive Officer and Director | 92.1K | 159.1K | — | — | — | — | 2.48M | 0.00% | ↗ |
| 19 | 2021 | Joseph Tucker Chief Executive Officer | 92.1K | 100.0K | 2.23M | — | 59.1K | — | 2.48M | 89.87% | ↗ |
| 20 | 2021 | Dr. Robert Wilkins Former Chief Medical Officer | 186.2K | — | — | — | — | — | 1.73M | 0.00% | ↗ |
| 21 | 2021 | Dr. Peter Facchini Chief Innovation Officer | 68.3K | 69.4K | — | — | — | — | 1.70M | 0.00% | ↗ |
| 22 | 2021 | Peter Facchini, Ph.D. Chief Innovation Officer | 68.3K | 40.4K | 1.57M | — | 29.0K | — | 1.70M | 91.92% | ↗ |
| 23 | 2020 | David Johnson Executive Chairman, Director, and Former Chief Executive Officer | — | 200.0K | — | — | — | — | 200.0K | 0.00% | ↗ |
| 24 | 2020 | David Johnson Executive Chairman | — | 200.0K | — | — | — | — | 200.0K | 0.00% | ↗ |
| 25 | 2020 | Avani Kanubaddi President and Chief Operating Officer | — | 60.0K | — | — | — | — | 60.0K | 0.00% | ↗ |
| 26 | 2018 | Brent Kelton | 250.0K | 100.0K | — | — | — | — | 350.0K | 0.00% | ↗ |
| 27 | 2017 | Viraj Patel Chief Financial Officer | 137.2K | — | — | 192.7K | — | — | 330.0K | 58.41% | ↗ |
| 28 | 2017 | Brent Kelton Chief Executive Officer | 121.5K | 50.0K | — | 117.0K | — | — | 288.5K | 40.55% | ↗ |
| 29 | 2017 | Giri Devanur Former President and Chief Executive Officer | 220.0K | 25.0K | — | — | — | — | 245.0K | 0.00% | ↗ |
| 30 | 2017 | Brent Kelton | 121.5K | 50.0K | — | — | — | — | 171.5K | 0.00% | ↗ |
| 31 | 2017 | Srinidhi (Dev) Devanur Executive Vice Chairman | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
| 32 | 2016 | Giri Devanur Former President and Chief Executive Officer | 175.0K | 57.5K | — | — | — | — | 232.5K | 0.00% | ↗ |
| 33 | 2016 | Srinidhi (Dev) Devanur Executive Vice Chairman | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
| 34 | 2015 | Devanur President | 120.0K | 25.0K | — | — | — | — | 145.0K | 0.00% | ↗ |
| 35 | 2015 | Giri | 90.0K | 45.0K | — | — | — | — | 135.0K | 0.00% | ↗ |
| 36 | 2014 | Devanur President | 66.0K | 6.0K | — | — | — | — | 72.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph Edward Tucker | Chief Executive Officer & Director | 472.4K | — |
| Kevin Coveney | Chief Financial Officer | 396.6K | male |
| Peter J. Facchini | Chief Innovation Officer | 221.8K | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ENVB
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
